HNN3.0

Project cooperationUpdated on 16 January 2026

Partner Search: 3D Organoid Expertise for High-Fidelity GBM Device Validation

Strategy & Research Associate at Migration Biotherapeutics

Cambridge, United Kingdom

About

Migration Biotherapeutics is developing the ALIGHT device, an innovative "ecological trap" designed to manage refractory glioblastoma by exploiting natural cell migratory instincts via aligned electrospun nanofibers.

Under the HORIZON-MISS-2026-02-CANCER-03 call, we are seeking research organisations specialising in high-fidelity 3D cancer organoid models and the replication of the tumour microenvironment. We seek to enhance the in vitro validation of our non-pharmacological device by testing its performance in complex 3D models that accurately mimic the human brain. This partnership is vital to establishing definitive proof-of-concept evidence. Migration Bio offers a unique industrial-academic bridge.

Similar opportunities